Skip to search formSkip to main contentSkip to account menu

AMD3100

Known as: AMD 3100, AMD-3100, SDZ SID 791 
A bicyclam with hematopoietic stem cell-mobilizing properties. AMD3100 blocks the binding of stromal cell-derived factor (SDF-1alpha) to the cellular… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Proliferation and migration of Cardiac Fibroblasts (CFBs) are important in early stage of myocardial fibrosis. The purpose of the… 
2012
2012
TO THE EDITOR: The article “Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium… 
2011
2011
AMD3100 for urgent PBSC mobilization and allogeneic transplantation from a normal donor after failed marrow harvest 
2011
2011
We have elucidated the binding sites of four moncyclam and one bicyclam antagonist AMD3100, in the human chemokine receptor CXCR4… 
2009
2009
Stem-cell collection before high-dose therapy for multiple myeloma: time has come to raise the standards! 
2008
2008
2007
2007
Purpose: The pattern of breast cancer metastasis may be determined by interactions between CXCR4 on breast cancer cells and… 
2006
2006
Hematopoietic stem cells (HSC) reside in the bone marrow (BM) and interact with stroma cells and extracellular matrix. CXCR4/SDF… 
2005
2005
G-CSF is currently the preferred agent to mobilize peripheral blood stem cells (PBSC) for allogeneic hematopoietic cell…